FDA Drug Application (022175) for PERTZYE by DIGESTIVE CARE INC

Back to FDA Applications sponsored by DIGESTIVE CARE INC

Application Number022175
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
Dosage30,250USP UNITS;8,000USP UNITS;28,750USP UNITS
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePERTZYE
Active IngredientPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Active IngredientCount
List of drugs with Active Ingredient AMYLASE7
List of drugs with Active Ingredient LIPASE7
List of drugs with Active Ingredient PANCRELIPASE7
List of drugs with Active Ingredient PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)7
List of drugs with Active Ingredient PROTEASE7


Back to FDA Applications sponsored by DIGESTIVE CARE INC